Our Take
Two conferences in one year signal healthcare's shift from AI ambition to accountability, but the field still lacks published deployment metrics that would let practitioners compare outcomes across systems.
Why it matters
Healthcare IT leaders are under pressure to show ROI on AI investments. Peer-reviewed case studies from real deployments—not vendor benchmarks—are what will actually move budgets from pilot to production.
Do this week
Healthcare IT leaders: register for one conference this quarter and commit to attending at least one clinical deployment breakout session, then audit your current AI use cases against whatever outcome metrics are presented.
Two major conferences tackle evidence-based AI in healthcare
HIMSS26 APAC runs August 23-25 in Singapore, convening health system leaders, government officials, clinicians, innovators, and technology vendors across the Asia-Pacific region. The stated focus: moving health systems from AI ambition to evidence-based action.
The AI in Healthcare Forum follows in Boston on June 25-26, with a two-day format aimed at clinicians, executives, technologists, researchers, and innovators. Both events position real-world application of AI in health and care as the centerpiece, not vendor pitches or theoretical frameworks.
Healthcare systems are drowning in AI pilots with no exit criteria
The language matters here. "Evidence-based action" is a direct rebuke of the pilot-to-pilot cycle that has locked many health systems into endless proof-of-concept work without deployment. Vendors have flooded healthcare with AI claims—diagnostic accuracy improvements, administrative workflow optimization, clinical decision support. Few of those claims rest on peer-reviewed outcomes data from actual patient populations.
A conference schedule that explicitly separates clinicians from vendors, and prioritizes real-world application over product launches, suggests organizers believe the field has a credibility problem. Healthcare IT budgets are finite. Boards want to know not just whether an AI system works in a vendor's lab, but whether it reduces clinician burnout, improves patient safety outcomes, or cuts administrative costs in their specific institution.
What to watch for at both events
If these conferences deliver value, they will surface case studies with named health systems, specific deployment timelines, measurable outcomes (reduction in order entry time, improvement in diagnostic agreement rates, drop in readmission rates), and candid accounts of what failed along the way.
Red flags: vendor-only benchmarks presented without independent validation, abstract statements about "AI transformation," or clinical speakers who are compensated by the vendors whose tools they discuss. The field has enough aspirational content.
The real test is whether attendees leave with deployment playbooks grounded in data, not inspiration. Healthcare moves slowly by design. Conferences that respect that reality and publish their proceedings openly will become planning documents for IT teams. Those that don't will be forgotten by Labor Day.